Funding · Company
Allotera Therapeutics, Inc.
St. Louis, MOHealthcare
Allotera Therapeutics, Inc. of St. Louis, MO has disclosed $259M across 3 Form D offerings filed with the SEC between Jul 23, 2021 and Jul 23, 2026.
$259M
Total disclosed
3
Form D offerings
2018
Incorporated
This CIK has filed under more than one name: Allotera Therapeutics, Inc., Wugen, Inc.. We use the most recent.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$123M
Form D · Jul 23, 2026 ↗
Q3 2026
· 1 amendment, first filed Sep 8, 2025
· target $163M
$99M
Form D · Jul 23, 2021 ↗
Q3 2021
· target $172M
Filing details
HeadquartersSt. Louis, MOIndustryHealthcare (Other Health Care)Incorporated2018SEC CIK0001874298Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →